Era Biology will host global live webinar at 30th June 2022 8:30 (GMT +08:00). The webinar will be in Spanish. The webinar will introduce the last technology for detecting invasive fungal disease. ...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
Latently infected cells harbor the HIV-1 proviral DNA genome primarily integrated into heterochromatin, allowing the persistence of transcriptionally silent proviruses. Hypoacetylation of histone p...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...